Literature DB >> 21380936

Renal biomarkers of kidney injury in cardiorenal syndrome.

Mark Comnick1, Areef Ishani.   

Abstract

The cardiorenal syndromes comprise a group of disorders in which impairment of either the heart or the kidney results in injury to the other. Although the pathophysiology is not yet well understood, the clinical consequences are increasingly recognized. In congestive heart failure, the development of worsening renal function is associated with increased hospitalizations and death. Urinary biomarkers offer a rapid and noninvasive method for detecting kidney injury. The role of urinary biomarkers such as neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, N-acetyl-β-D-glucosaminidase, interleukin-18, and cystatin C are being investigated to provide diagnostic, prognostic, and, eventually, therapeutic information. This article reviews the utility of urinary biomarkers in congestive heart failure and explores directions for future research.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21380936     DOI： 10.1007/s11897-011-0052-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  59 in total

1.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

Review 2.  Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction?

Authors:  Jolanta Malyszko; Vladimir Tesar; Iain C Macdougall
Journal:  Kidney Blood Press Res       Date:  2010-05-26       Impact factor: 2.687

3.  Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.

Authors:  Maria Rosa Costanzo; Mitchell T Saltzberg; Mariell Jessup; John R Teerlink; Paul A Sobotka
Journal:  J Card Fail       Date:  2010-02-04       Impact factor: 5.712

4.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 6.  Early biomarkers of renal injury.

Authors:  Dinna N Cruz; Ching Yan Goh; Anja Haase-Fielitz; Claudio Ronco; Michael Haase
Journal:  Congest Heart Fail       Date:  2010-07

7.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

8.  Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression.

Authors:  A Friedl; S P Stoesz; P Buckley; M N Gould
Journal:  Histochem J       Date:  1999-07

Review 9.  Cardiorenal syndrome in acute decompensated heart failure.

Authors:  Mohammad Sarraf; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

10.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

Authors:  Kevin Damman; Gerjan Navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur J Heart Fail       Date:  2007-06-22       Impact factor: 15.534
View more
  8 in total

Review 1.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Novel biomarkers in chronic heart failure.

Authors:  Tariq Ahmad; Mona Fiuzat; G Michael Felker; Christopher O'Connor
Journal:  Nat Rev Cardiol       Date:  2012-03-27       Impact factor: 32.419

3.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

4.  Anemia in heart failure patients.

Authors:  Michael G Alexandrakis; George Tsirakis
Journal:  ISRN Hematol       Date:  2012-03-25

5.  The independent association between altered renal arterial resistance and loop diuretic dose in chronic heart failure outpatients.

Authors:  Massimo Iacoviello; Annalisa Doronzo; Valeria Paradies; Valeria Antoncecchi; Francesco Monitillo; Gaetano Citarelli; Marta Leone; Agata Puzzovivo; Loreto Gesualdo; Marco Matteo Ciccone
Journal:  Int J Cardiol Heart Vasc       Date:  2015-03-25

Review 6.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 7.  Acute Kidney Injury in Pediatric Heart Failure.

Authors:  Alyssa Riley; Daniel J Gebhard; Ayse Akcan-Arikan
Journal:  Curr Cardiol Rev       Date:  2016

8.  Cardiorenal syndrome in thalassemia patients.

Authors:  Sorasak Makmettakul; Adisak Tantiworawit; Arintaya Phrommintikul; Pokpong Piriyakhuntorn; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada; Kanda Fanhchaksai; Pimlak Charoenkwan; Suree Lekawanvijit
Journal:  BMC Nephrol       Date:  2020-08-03       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.